Clinical Outcomes With Immune Checkpoint Inhibitors in Patients With FGFR2/3, MTAP or ERBB2 Genomic Alterations in Advanced Urothelial Carcinoma
Titel:
Clinical Outcomes With Immune Checkpoint Inhibitors in Patients With FGFR2/3, MTAP or ERBB2 Genomic Alterations in Advanced Urothelial Carcinoma
Auteur:
Talukder, Rafee Bakaloudi, Dimitra Rafailia Makrakis, Dimitrios Diamantopoulos, Leonidas N. Enright, Thomas Leary, Jacob B. Raychaudhuri, Ruben Tripathi, Nishita Agarwal, Neeraj Jindal, Tanya Brown, Jason R. Zakharia, Yousef Rey-Cárdenas, Macarena Castellano, Daniel Nguyen, Charles B. Alva, Ajjai Zakopoulou, Roubini Bamias, Aristotelis Barrera, Rafael Morales Marmolejo, David Drakaki, Alexandra Pinato, David J. Korolewicz, James Buznego, Lucia Alonso Duran, Ignacio Carballeira, Clara Castro McKay, Rana R. Stewart, Tyler F. Gupta, Shilpa Barata, Pedro Yu, Evan Y. Koshkin, Vadim S. Khaki, Ali Raza Grivas, Petros